European Lithium's takeover by Critical Metals shifts to a variable share ratio, with court hearing Sept 15 and completion ...

Czech defence group CSG sees shares halve from January peak despite record orders, new execs, and solid H1 results.

There is a peculiar disconnect playing out at Rocket Lab right now. On one side of the ledger sits a company executing with ...

Investors parsing Bayer's second-quarter numbers are confronting a company that is simultaneously healing and straining. The German life-science group delivered ...

There is a curious tension at Micron Technology right now. The memory maker is committing to a ten-year research vision and ...

Rheinmetall invests €270M in Kassel plant, but shares fall 2.1% as investors question order-to-revenue conversion amid €80.5B ...

Moody's confirms Allianz's credit rating; shares near 52-week high at €452.90, with mixed analyst targets from €325 to €465.

The Danish drugmaker is presenting investors with a puzzle: its own treasury desk is hoovering up shares at a record clip, ...

BrainChip ships 2,000 AKD1500 processors, but half-year net loss widens to $12.02M as revenue reaches $1.22M, highlighting ...

Salesforce's Q2 beat includes $2.6B Anthropic paper gain; core EPS growth ~16%. Agentforce ARR up 240%, but organic growth ...

The approval landed without fanfare. The market's reaction, however, told a more complicated story about where BioNTech's ...

The race to dominate artificial intelligence hosting is no longer just about silicon and data centers — it's increasingly about who gets to rent out the smartes ...